American Trust Invests $227,000 in Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP)

American Trust bought a new position in shares of Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP – Get Rating) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 3,177 shares of the company’s stock, valued at approximately $227,000.

Other institutional investors also recently modified their holdings of the company. Citadel Advisors LLC purchased a new stake in Invesco Dynamic Pharmaceuticals ETF in the 3rd quarter valued at $1,408,000. Commonwealth Equity Services LLC raised its position in Invesco Dynamic Pharmaceuticals ETF by 2.9% in the 3rd quarter. Commonwealth Equity Services LLC now owns 25,584 shares of the company’s stock valued at $1,824,000 after buying an additional 726 shares during the last quarter. United Capital Financial Advisers LLC purchased a new stake in Invesco Dynamic Pharmaceuticals ETF in the 3rd quarter valued at $271,000. Royal Bank of Canada raised its position in Invesco Dynamic Pharmaceuticals ETF by 20.9% in the 3rd quarter. Royal Bank of Canada now owns 11,819 shares of the company’s stock valued at $842,000 after buying an additional 2,040 shares during the last quarter. Finally, Peak Asset Management LLC raised its position in Invesco Dynamic Pharmaceuticals ETF by 2.7% in the 3rd quarter. Peak Asset Management LLC now owns 128,761 shares of the company’s stock valued at $9,181,000 after buying an additional 3,393 shares during the last quarter.

Invesco Dynamic Pharmaceuticals ETF Trading Down 1.9 %

NYSEARCA PJP opened at $73.79 on Friday. The firm has a market capitalization of $307.71 million, a P/E ratio of 14.11 and a beta of 0.69. The business has a fifty day simple moving average of $77.50 and a 200 day simple moving average of $76.45. Invesco Dynamic Pharmaceuticals ETF has a 12 month low of $68.59 and a 12 month high of $84.11.

Invesco Dynamic Pharmaceuticals ETF Profile

(Get Rating)

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.